2-hydroxy-2-(naphth-2-yl)propionic acid | 76561-82-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-hydroxy-2-(naphth-2-yl)propionic acid
• 英文别名: 2-hydroxy-2-(naphthalen-2-yl)propanoic acid；alpha-Hydroxy-alpha-methyl-2-naphthaleneacetic acid；2-hydroxy-2-naphthalen-2-ylpropanoic acid
• CAS: 76561-82-5
• 化学式: C₁₃H₁₂O₃
• 分子量: 216.236
• InChiKey: KUJHPYMDWIIJDD-UHFFFAOYSA-N

物化性质

• 熔点：
  155 °C (decomp)
• 沸点：
  431.4±25.0 °C(Predicted)
• 密度：
  1.303±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (+/-)-methyl 2-hydroxy-2-(2-naphthyl)propionate 在 氢氧化钾 作用下， 以 甲醇 为溶剂， 反应 2.0h， 以84%的产率得到2-hydroxy-2-(naphth-2-yl)propionic acid
  参考文献：
  名称：

  脂肪酶对2-氟-2-芳基丙酸甲酯的酶促水解作用

  摘要：

  2-氟-2-芳基丙酸甲酯的酶促水解是使用来自皱念珠菌和圆柱形念珠菌（OF-360）的脂肪酶进行的。对反应产物的仔细分析表明，除了预期的2-芳基-2-氟丙酸外，还形成了外消旋的2-羟基-2-芳基丙酸和痕量的2-芳基丙烯酸。在底物的芳环中存在强电子释放基团增加了2-羟基丙酸的量。已建立了一种机制假说，根据该假说，酶促进了水解酸中氟离子的清除，并形成了α-羧基稳定的碳阳离子，该羧基通过H 2的亲核攻击提供了2-羟基丙酸。通过β-消除方法得到O和2-芳基丙烯酸。

  DOI：

  10.1016/j.tet.2005.06.007

文献信息

• GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS
  申请人：South Dakota Board of Regents

  公开号：US20200048305A1

  公开（公告）日：2020-02-13

  The present invention describes compositions containing cholesterol-linker-glutathione conjugates for targeting the brain by overcoming barrier entry to the CNS through the blood brain barrier (BBB), including micelle and liposome forms of such compositions. In addition, methods for treating subjects by administering such compositions are also disclosed.

  本发明描述了含有胆固醇-连接剂-谷胱甘肽共轭物的组合物，通过克服血脑屏障（BBB）进入中枢神经系统的屏障入口，包括这些组合物的胶束和脂质体形式。此外，还公开了通过给予这些组合物治疗受试者的方法。
• Photocatalytic Carbinol Cation/Anion Umpolung: Direct Addition of Aromatic Aldehydes and Ketones to Carbon Dioxide
  作者：Shintaro Okumura、Yasuhiro Uozumi

  DOI：10.1021/acs.orglett.1c02592

  日期：2021.9.17

  We have developed a new photocatalytic umpolung reaction of carbonyl compounds to generate anionic carbinol synthons. Aromatic aldehydes or ketones reacted with carbon dioxide in the presence of an iridium photocatalyst and 1,3-dimethyl-2-phenyl-2,3-dihydro-1H-benzimidazole (DMBI) as a reductant under visible-light irradiation to furnish the corresponding α-hydroxycarboxylic acids through nucleophilic

  我们开发了一种新的羰基化合物光催化聚合反应，以生成阴离子甲醇合成子。芳香醛或酮在铱光催化剂和 1,3-二甲基-2-苯基-2,3-二氢-1 H-苯并咪唑 (DMBI) 作为还原剂的存在下与二氧化碳反应，在可见光照射下提供通过将所得的甲醇阴离子与亲电二氧化碳进行亲核加成，生成相应的α-羟基羧酸。
• Electrochemical carboxylation of aldehydes and ketones with sacrificial aluminum anodes.
  作者：G. Silvestri、S. Gambino、G. Filardo

  DOI：10.1016/s0040-4039(00)84814-5

  日期：1986.1

  impossible with conventional electrochemical systems. It is reported here that it is possible to realize it in diaphragmless cells making of sacrificial aluminum anodes. The method can be used also for the electrocarboxylation of ketones with good yields.

  用常规电化学系统不可能将醛电羧化为相应的α-羟基酸。据报道，在由牺牲铝阳极制成的无隔膜电池中可以实现这一点。该方法还可以以良好的产率用于酮的电羧化。
• NOVEL ESTER COMPOUND AND PIN1 INHIBITOR, INFLAMMATORY DISEASE THERAPEUTIC, AND COLON CANCER THERAPEUTIC IN WHICH SAID ESTER COMPOUND IS USED
  申请人：Hiroshima University

  公开号：EP3549930A1

  公开（公告）日：2019-10-09

  An object of the present invention is to develop a therapeutic agent for an inflammatory disease such as an inflammatory bowel disease or NASH, which therapeutic agent shows less side effects and high effectiveness. The present invention provides a compound represented by Formula (I) or a salt thereof; and a Pin1 inhibitor, a pharmaceutical composition, a therapeutic agent or a prophylactic agent for an inflammatory disease, and a therapeutic agent or a prophylactic agent for colon cancer, containing the compound.

  本发明的目的是开发一种用于炎症性疾病（如炎症性肠病或 NASH）的治疗剂，该治疗剂副作用小且疗效显著。本发明提供了一种由式（I）代表的化合物或其盐；以及一种含有该化合物的 Pin1 抑制剂、一种药物组合物、一种炎症性疾病的治疗剂或预防剂，以及一种结肠癌的治疗剂或预防剂。
• Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon cancer therapeutic in which said ester compound is used
  申请人：Hiroshima University

  公开号：US11203565B2

  公开（公告）日：2021-12-21

  An object of the present invention is to develop a therapeutic agent for an inflammatory disease such as an inflammatory bowel disease or NASH, which therapeutic agent shows less side effects and high effectiveness. The present invention provides a compound represented by Formula (I) or a salt thereof; and a Pin1 inhibitor, a pharmaceutical composition, a therapeutic agent or a prophylactic agent for an inflammatory disease, and a therapeutic agent or a prophylactic agent for colon cancer, containing the compound.

  本发明的目的是开发一种用于炎症性疾病（如炎症性肠病或 NASH）的治疗剂，该治疗剂副作用小且疗效显著。本发明提供了一种由式（I）代表的化合物或其盐；以及一种含有该化合物的 Pin1 抑制剂、一种药物组合物、一种炎症性疾病的治疗剂或预防剂，以及一种结肠癌的治疗剂或预防剂。